Patterns and Prevalence of Psychiatric Comorbidities in Individuals with Substance Use Disorders: A Retrospective Analysis
International Journal of Pharmaceutical Quality Assurance · 10.07.2026 · 16 (11)
DOI: 10.25258/ijpqa.16.11.119 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 10.07.2026. Verfasst von Sushil Kumar und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Psychiatric comorbidities frequently co-occur with substance use disorders (SUDs), complicating clinical management and affecting ‘ treatment outcomes. Understanding these patterns is crucial for effective interventions.
Aim
To examine the prevalence and patterns of psychiatric comorbidities among individuals with SUDs attending a tertiary care hospital in the Bihar region. Methodology: This retrospective observational study reviewed medical records of 80 patients aged 18–60 years diagnosed with SUDs over a 7-month period. Demographic data, substance use patterns, and psychiatric comorbidities were extracted using a semi-structured proforma and analyzed using SPSS v27. Descriptive statistics and chi-square tests assessed associations between substance type and comorbidities.
Results
Majority of participants were male (77.5%), aged 26–35 years (35%), and married (55%). Alcohol (62.5%) and tobacco (52.5%) were the most commonly used substances. Psychiatric comorbidities were present in 91.2% of participants, with mood disorders (37.5%) and anxiety disorders (25%) being most prevalent. Polysubstance and cannabis users showed the highest comorbidity proportions. Males exhibited higher rates across most psychiatric conditions.
Conclusion
Psychiatric comorbidities are highly prevalent among individuals with SUDs, even with relatively short duration of use. Early identification and integrated treatment addressing both substance use and mental health are essential to improve outcomes
Zitieren
APA
Kumar, S., Kumar, A., & Jha, V. N. (2026). Patterns and Prevalence of Psychiatric Comorbidities in Individuals with Substance Use Disorders: A Retrospective Analysis. International Journal of Pharmaceutical Quality Assurance, 16(11). https://doi.org/10.25258/ijpqa.16.11.119
Vancouver
Kumar S, Kumar A, Jha VN. Patterns and Prevalence of Psychiatric Comorbidities in Individuals with Substance Use Disorders: A Retrospective Analysis. International Journal of Pharmaceutical Quality Assurance. 2026;16(11). doi:10.25258/ijpqa.16.11.119
BibTeX
@article{Kumar2026,
author = {Kumar, Sushil and Kumar, Amit and Jha, Vijendra Nath},
title = {Patterns and Prevalence of Psychiatric Comorbidities in Individuals with Substance Use Disorders: A Retrospective Analysis},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {11},
doi = {10.25258/ijpqa.16.11.119}
}
EUVIMED